These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1259524)

  • 21. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    Hulse GK; O'Neil G; Arnold-Reed DE
    Int J Gynaecol Obstet; 2004 May; 85(2):170-1. PubMed ID: 15099783
    [No Abstract]   [Full Text] [Related]  

  • 26. Tailor made for the job?
    Brewer C
    Nurs Times; 1986 Aug 27-Sep 2; 82(35):42-3. PubMed ID: 3639451
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of methadone in the treatment of narcotic addiction].
    Tiljak H
    Lijec Vjesn; 1998 May; 120(5):125-31. PubMed ID: 9748791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
    Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
    Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heroin addiction and motivational milieu therapy.
    Van Bilsen HP; van Emst AJ
    Int J Addict; 1986 Jun; 21(6):707-13. PubMed ID: 3744621
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
    Salamina G; Diecidue R; Vigna-Taglianti F; Jarre P; Schifano P; Bargagli AM; Davoli M; Amato L; Perucci CA; Faggiano F;
    Subst Use Misuse; 2010 Oct; 45(12):2076-92. PubMed ID: 20438317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heroin addiction treated with methadone. Experience in 50 patients].
    Olié JP; Kecskemeti S; Poirier MF; Laqueille X; Perron JL; Lôo H
    Presse Med; 1991 Aug 31-Sep 7; 20(27):1253-8. PubMed ID: 1832759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From IM morphine to PO methadone.
    Strauss A
    West J Med; 1980 Dec; 133(6):520. PubMed ID: 7467309
    [No Abstract]   [Full Text] [Related]  

  • 33. Contemporary methods in pharmacotherapy in the opiate dependent treatment.
    Radomska M; Bisaga A; Popik P
    Przegl Lek; 2000; 57(10):509-18. PubMed ID: 11199877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 35. Substitution treatment in Malaysia.
    Noordin NM; Merican MI; Rahman HA; Lee SS; Ramly R
    Lancet; 2008 Sep; 372(9644):1149-50. PubMed ID: 18926274
    [No Abstract]   [Full Text] [Related]  

  • 36. [Methadone treatment of heroin addiction in family practice. Risks and guidelines].
    Hartmann H; Uchtenhagen A; Fuchs W; Pasi A
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):299-304. PubMed ID: 6709990
    [No Abstract]   [Full Text] [Related]  

  • 37. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating heroin addiction: comparison of methadone therapy, hospital therapy without methadone, and therapeutic community.
    Vidjak N
    Croat Med J; 2003 Feb; 44(1):59-64. PubMed ID: 12590430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of narcotic addict treatment in California.
    Anglin MD; McGlothlin WH
    NIDA Res Monogr; 1984; 51():106-28. PubMed ID: 6438513
    [No Abstract]   [Full Text] [Related]  

  • 40. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.